Home » Topics » BioWorld Science

BioWorld Science
RSS

Early interim data and regulatory update for phase II TRIDENT-1 study of repotrectinib

Aug. 20, 2020

Novel 3C-like protease inhibitors show efficacy in MERS-CoV-infected mice

Aug. 20, 2020

BioMarin receives complete response letter from FDA for valoctocogene roxaparvovec

Aug. 20, 2020

Shionogi describes identification of clinical candidate P2X3 receptor antagonist S-600918

Aug. 20, 2020

Trefoil Therapeutics initiates first clinical trial of TTHX-1114

Aug. 20, 2020

First patient dosed in phase I/II study of 4D-125

Aug. 20, 2020

Alkermes initiates phase II ARTISTRY-3 study of ALKS-4230

Aug. 20, 2020

Betta Pharmaceuticals identifies new SHP-2 inhibitors

Aug. 20, 2020

Medshine Discovery patents c-Met inhibitors

Aug. 20, 2020

New STING receptor agonists identified at HitGen

Aug. 20, 2020

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...